EirGenix has core capacity in R&D and manufacturing, producing biologics compliant with PIC/S GMP standard, and has 7 products undergoing development.
(1) Cell Line Development & Cell Banking Service
(2) Contract Development & Manufacturing Service
(3) Contract Research (CRO) & QC analysis Service
(4) Antibody Drug Conjugate (ADC) service (Partnering with Formosa Laboratories, Ltd.)
2. Product Pipeline:
(1) EG12014 (Trastuzumab Biosimilar)
(2) EG1206X (Pertuzumab Biosimilar)
(3) EG13074 (New Formulation)
(4) FP0110 (EG12043) (Antibody-Drug Conjugate)
(5) EG12021 (Biosimilar)
(6) EG74032 (Carrier Protein)
(7) EG6205X (Biosimilar)
Cooperation projects and needs
1.We are looking for customers who need service of Contract Development & Manufacturing of biologics compliant with PIC/S GMP.
2.We are looking for partners who need potential biologics in development for further collaboration and investment.